Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
|Active Ingredient:||Perampanel hemisesquihydrate 0.52mg/mL equivalent to perampanel 0.5mg/mL|
|Dosage Form:||Oral suspension|
|New Zealand Sponsor:||Eisai New Zealand Limited|
|Manufacturers:||Delpharm Huningue SAS, Huningue, France
Eisai Manufacturing Limited, Hatfield, United Kingdom
|Product:||Sensodyne Daily Care Extra Whitening|
|Active Ingredients:||Potassium nitrate 5%w/w
Sodium fluoride 0.3152%w/w
|New Zealand Sponsor:||GlaxoSmithKline Consumer Healthcare New Zealand ULC|
|Manufacturer:||Neocosmed Co Limited, Pathumthani, Thailand|
Dated this 22nd day of April 2022.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).